Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BioGeneration Ventures Leads Europe's Seed Investing With New Fund

Oct 31 2017

• By John Davis

Naarden — The historic town hall in Naarden • Source: Shutterstock

Related Content

Amgen acquires 'cheaper, oral' alternative to Repatha

Sep 16 2015

AstraZeneca In Buy Now, Pay In Full Later Deal For Majority Acerta Stake

Dec 17 2015

Bio Boost For Benelux As BioGeneration Ventures Beats Fund Target

Jun 27 2017

Related Companies

Bristol Myers Squibb Company

Dezima Pharma

Amgen, Inc.

Acerta Pharma BV

AstraZeneca PLC

Additional Topics

Europe Financing StartUps and SMEs Commercial Cancer BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.